Is rasagiline covered by medical insurance?

In people with Parkinson's disease, dopamine-producing cells begin to die, the amount of dopamine in the brain decreases, and patients lose the ability to reliably control their movements. By increasing dopamine levels in the part of the brain that controls movement and coordination, rasagiline improves the signs and symptoms of Parkinson's disease, such as stiffness and slowness of movement. The active substance Rasagiline is a "monoamine oxidase B inhibitor".

Rasagiline blocks type B monoamine oxidase, an enzyme that breaks down the neurotransmitter dopamine in the brain. Neurotransmitters are chemicals that allow nerve cells to communicate with each other. Rasagiline may also be used as an adjunct to levodopa in patients who experience "surges" at the end of levodopa dosing intervals. Fluctuations are associated with diminished effects of levodopa, when patients experience sudden transitions between "on" and being able to move, and "off" and being immobile. Rasagiline is currently only available by prescription.

The original drug of rasagiline has been launched in China and has entered the category of Class B medical insurance. The common name is rasagiline mesylate tablets, and the specifications areThe price of each box of 1mg*14 tablets may be around RMB 600. The price of the Turkish version of rasagiline's original drug, 1mg*30 tablets, per box sold overseas may be around RMB 310 (the price may fluctuate due to exchange rates). There are also generic drugs produced in other countries. The price of a box of 1mg*100 tablets produced by an Indian pharmaceutical factory may be around RMB 240 (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs. For specific prices and drug information, please consult Yaode Medical Consultants.